Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-25

FDA Approved: ARGATROBAN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Argatroban from Fresenius Kabi USA, LLC. This action constitutes a supplemental approval rather than a full approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Argatroban (argatroban)

Snippet

SUPPL AP for ARGATROBAN (ARGATROBAN)